Evogene Statistics
Total Valuation
Evogene has a market cap or net worth of ILS 38.23 million. The enterprise value is 61.45 million.
Market Cap | 38.23M |
Enterprise Value | 61.45M |
Important Dates
The last earnings date was Thursday, August 14, 2025.
Earnings Date | Aug 14, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Evogene has 8.71 million shares outstanding. The number of shares has increased by 32.58% in one year.
Current Share Class | 8.71M |
Shares Outstanding | 8.71M |
Shares Change (YoY) | +32.58% |
Shares Change (QoQ) | +6.29% |
Owned by Insiders (%) | 0.99% |
Owned by Institutions (%) | 1.85% |
Float | 8.63M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.20 |
PB Ratio | 0.92 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.28 |
EV / Sales | 1.93 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -1.00 |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 0.21.
Current Ratio | 1.89 |
Quick Ratio | 0.89 |
Debt / Equity | 0.21 |
Debt / EBITDA | n/a |
Debt / FCF | -0.15 |
Interest Coverage | -20.26 |
Financial Efficiency
Return on equity (ROE) is -98.38% and return on invested capital (ROIC) is -66.04%.
Return on Equity (ROE) | -98.38% |
Return on Assets (ROA) | -31.55% |
Return on Invested Capital (ROIC) | -66.04% |
Return on Capital Employed (ROCE) | -100.92% |
Revenue Per Employee | 271,963 |
Profits Per Employee | -410,450 |
Employee Count | 117 |
Asset Turnover | 0.25 |
Inventory Turnover | 2.68 |
Taxes
In the past 12 months, Evogene has paid 30,324 in taxes.
Income Tax | 30,324 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -70.92% in the last 52 weeks. The beta is 1.41, so Evogene's price volatility has been higher than the market average.
Beta (5Y) | 1.41 |
52-Week Price Change | -70.92% |
50-Day Moving Average | 453.83 |
200-Day Moving Average | 497.79 |
Relative Strength Index (RSI) | 43.94 |
Average Volume (20 Days) | 40,362 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Evogene had revenue of ILS 31.82 million and -48.02 million in losses. Loss per share was -7.21.
Revenue | 31.82M |
Gross Profit | 19.39M |
Operating Income | -63.69M |
Pretax Income | -53.52M |
Net Income | -48.02M |
EBITDA | -58.38M |
EBIT | -63.69M |
Loss Per Share | -7.21 |
Balance Sheet
The company has 39.39 million in cash and 8.96 million in debt, giving a net cash position of 30.43 million or 3.49 per share.
Cash & Cash Equivalents | 39.39M |
Total Debt | 8.96M |
Net Cash | 30.43M |
Net Cash Per Share | 3.49 |
Equity (Book Value) | 41.70M |
Book Value Per Share | -1.66 |
Working Capital | 45.32M |
Cash Flow
In the last 12 months, operating cash flow was -59.36 million and capital expenditures -1.96 million, giving a free cash flow of -61.32 million.
Operating Cash Flow | -59.36M |
Capital Expenditures | -1.96M |
Free Cash Flow | -61.32M |
FCF Per Share | -7.04 |
Margins
Gross margin is 60.93%, with operating and profit margins of -200.17% and -150.92%.
Gross Margin | 60.93% |
Operating Margin | -200.17% |
Pretax Margin | -168.21% |
Profit Margin | -150.92% |
EBITDA Margin | -183.48% |
EBIT Margin | -200.17% |
FCF Margin | n/a |
Dividends & Yields
Evogene does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -32.58% |
Shareholder Yield | n/a |
Earnings Yield | -125.62% |
FCF Yield | -160.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on July 28, 2024. It was a reverse split with a ratio of 0.1.
Last Split Date | Jul 28, 2024 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |